Assyro AI

Orange Book product · Generic (ANDA)

SULINDAC

SULINDAC

Generic (ANDA)ANDA 072973DISCN ANI PHARMS

At a glance

Feb 28, 1992

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 28, 1992

    34 yr 10 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

SULINDAC

Strength

150MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

ANDA 072973

Product number

002

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of SULINDAC

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.